Upgrade to SI Premium - Free Trial

BioCryst Pharma (BCRX)

8.41 -0.06 (0.71%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Form 4 BIOCRYST PHARMACEUTICALS For: May 29 Filed by: Milne Jill C. June 2, 2026 4:16 PM - SEC Filing Form 4 BIOCRYST PHARMACEUTICALS For: May 29 Filed by: Stonehouse Jon P June 2, 2026 4:14 PM - SEC Filing Form 4 BIOCRYST PHARMACEUTICALS For: May 29 Filed by: McKee Amy E June 2, 2026 4:11 PM - SEC Filing Form 4 BIOCRYST PHARMACEUTICALS For: May 29 Filed by: MILANO VINCENT June 2, 2026 4:09 PM - SEC Filing Form 4 BIOCRYST PHARMACEUTICALS For: May 29 Filed by: Frank Steven June 2, 2026 4:07 PM - SEC Filing BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting May 27, 2026 7:00 AM - Globe NewsWire Form 4 BIOCRYST PHARMACEUTICALS For: May 18 Filed by: McKee Amy E May 19, 2026 4:08 PM - SEC Filing Form 144 BIOCRYST PHARMACEUTICALS Filed by: McKee Amy E May 18, 2026 4:48 PM - SEC Filing Form 4 BIOCRYST PHARMACEUTICALS For: May 13 Filed by: Barnes Alane P May 15, 2026 4:13 PM - SEC Filing Form 144 BIOCRYST PHARMACEUTICALS Filed by: Barnes Alane P May 13, 2026 1:06 PM - SEC Filing BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026 May 13, 2026 7:00 AM - Globe NewsWire Form SCHEDULE 13G BIOCRYST PHARMACEUTICALS Filed by: STATE STREET CORP May 12, 2026 10:00 AM - SEC Filing BioCryst Pharma (BCRX) PT Raised to $28 at Citizens Amid Steady New Patient Starts May 7, 2026 5:02 AM - StreetInsider Form 10-Q BIOCRYST PHARMACEUTICALS For: Mar 31 May 6, 2026 4:08 PM - SEC Filing Form 8-K BIOCRYST PHARMACEUTICALS For: May 06 May 6, 2026 7:08 AM - SEC Filing BioCryst Pharma (BCRX) Misses Q1 EPS by 303c ; Offers Guidance May 6, 2026 7:05 AM - StreetInsider BioCryst Reports First Quarter 2026 Financial Results and Provides Business Update May 6, 2026 7:00 AM - Globe NewsWire BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 5, 2026 7:01 AM - Globe NewsWire Form 8-K BIOCRYST PHARMACEUTICALS For: May 04 May 4, 2026 7:07 AM - SEC Filing BioCryst licenses navenibart to Neopharmed Gentili for European market May 4, 2026 7:01 AM - StreetInsider BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema May 4, 2026 7:00 AM - Globe NewsWire Form SCHEDULE 13G BIOCRYST PHARMACEUTICALS Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 29, 2026 5:03 PM - SEC Filing BioCryst to Present at Upcoming Investor Conferences April 28, 2026 7:00 AM - Globe NewsWire Form DEF 14A BIOCRYST PHARMACEUTICALS For: Jun 11 April 23, 2026 7:18 PM - SEC Filing Form ARS BIOCRYST PHARMACEUTICALS For: Dec 31 April 23, 2026 7:06 PM - SEC Filing Form DEFA14A BIOCRYST PHARMACEUTICALS April 23, 2026 7:06 PM - SEC Filing BioCryst to Report First Quarter 2026 Financial Results on May 6 April 15, 2026 7:00 AM - Globe NewsWire Form 4 BIOCRYST PHARMACEUTICALS For: Apr 06 Filed by: Menon Sandeep April 7, 2026 4:25 PM - SEC Filing Form 3 BIOCRYST PHARMACEUTICALS For: Apr 06 Filed by: Menon Sandeep April 7, 2026 4:23 PM - SEC Filing BioCryst Pharma (BCRX) PT Raised to $14 at RBC Capital April 7, 2026 9:02 AM - StreetInsider BioCryst names Sandeep Menon as chief research and development officer April 6, 2026 7:00 AM - StreetInsider BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer April 6, 2026 7:00 AM - Globe NewsWire BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 3, 2026 7:00 AM - Globe NewsWire Form SCHEDULE 13G/A BIOCRYST PHARMACEUTICALS Filed by: VANGUARD GROUP INC March 26, 2026 4:10 PM - SEC Filing RBC Capital: 'Takeout Analysis Suggests BCRX Shares Still Undervalued' March 25, 2026 6:11 AM - StreetInsider Form 4 BIOCRYST PHARMACEUTICALS For: Mar 20 Filed by: HEGGIE THERESA March 24, 2026 4:04 PM - SEC Filing Form 144 BIOCRYST PHARMACEUTICALS Filed by: HEGGIE THERESA March 20, 2026 11:37 AM - SEC Filing Form 4 BIOCRYST PHARMACEUTICALS For: Mar 16 Filed by: Barnes Alane P March 18, 2026 4:11 PM - SEC Filing RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns' March 18, 2026 9:21 AM - StreetInsider Form 144 BIOCRYST PHARMACEUTICALS Filed by: Barnes Alane P March 16, 2026 4:18 PM - SEC Filing BioCryst Pharma (BCRX) shares quickly gain March 16, 2026 10:52 AM - StreetInsider Full Article List